Subscribe Now
  • Home
  • Latest
    • News
    • North America
    • Europe
    • Asia
    • Middle East
    • Global
  • Coins2Day 500
    • Coins2Day 500 U.S.
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
  • Finance
    • Economy
    • Banking
    • Personal Finance
    • Investing
    • Real Estate
    • Energy
    • Crypto
  • Tech
    • Big Tech
    • Startups & Venture
    • AI
    • Innovation
    • Cybersecurity
  • Leadership
    • Future Of Work
    • Success
    • C-Suite
    • Workplace Culture
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Health
    • Travel & Leisure
    • Education
  • Rankings
    • Great Place To Work
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Press Releases
    • Video
    • Podcasts
  • Home
  • Latest
    • Latest
    • News
    • North America
    • Europe
    • Asia
    • Middle East
    • Global
  • Coins2Day 500
    • Coins2Day 500
    • Coins2Day 500 U.S.
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
  • Finance
    • Finance
    • Economy
    • Banking
    • Personal Finance
    • Investing
    • Real Estate
    • Energy
    • Crypto
  • Tech
    • Tech
    • Big Tech
    • Startups & Venture
    • AI
    • Innovation
    • Cybersecurity
  • Leadership
    • Leadership
    • Future Of Work
    • Success
    • C-Suite
    • Workplace Culture
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Health
    • Travel & Leisure
    • Education
  • Rankings
    • Rankings
    • Great Place To Work
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Press Releases
    • Video
    • Podcasts
  1. home
  1. home
  2. medical technology

medical technology

Page 3 of 3

A file photo showing the EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company are seen in Washington
Health

Mylan’s Massive Recall of Faulty EpiPens Spreads to the U.S.

By Aric Jenkins
April 1, 2017
The Science Museum Unveils Their Latest Exhibition "Robotville" Displaying The Most Cutting Edge In European Design
Health

New Implant Method Could Give Amputees Direct Nerve Control of Artificial Limbs

By David Z. Morris
February 12, 2017
US-HOLIDAY-INDEPENDENCE DAY-MARIJUANA-MARKET
Tech

Hackers Cripple Leading Marijuana Sales System

By David Z. Morris
January 15, 2017
Why Robots Can Be Better Surgeons
Tech

Why Robots Can Be Better Surgeons

By Maxine Wally
July 11, 2016
3D Printing Has Changed the Prosthetics Business
Tech

3D Printing Has Changed the Prosthetics Business

By Maxine Wally
July 8, 2016
General Motors and NASA Are Lending a Robotic Hand to Healthcare

General Motors and NASA Are Lending a Robotic Hand to Healthcare

By Jonathan Vanian
July 6, 2016
545861099
Health

First CRISPR Clinical Trial in Humans Is Approved by Federal Regulators

By STAT News
June 22, 2016
Napster co-founder, Sean Parker, General
Health

Sean Parker Is Funding the First Human Trials of a Revolutionary Cancer Treatment

By Laura Lorenzetti
June 21, 2016
The First Implant to Treat Opioid Addiction Just Got Approved
Health

The First Implant to Treat Opioid Addiction Just Got Approved

By Sy Mukherjee
May 26, 2016

Most Popular

  • North America
    Gates Foundation plans to give away $9 billion in 2026 to prepare for the 2045 closure while slashing hundreds of jobs
    By Sydney Lake
  • Europe
    Denmark offered to trade Greenland to the U.S. in 1910—and America thought it was crazy
    By Steven Lamy and The Conversation
  • Personal Finance
    Sweden abolished its wealth tax 20 years ago. Then it became a 'paradise for the super-rich'
    By Miranda Sheild Johansson and The Conversation
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work at Coins2Day
  • Diversity and Inclusion
  • Terms and Conditions
  • Site Map

© 2026 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.